[Norplant contraception at the Rabta Tunis maternity hospital].
Chelli
H
H
Sfar
E
E
Zouari
F
F
Habibi
H
H
Rouis
M
M
Messaad
J
J
Ouerghemmi
R
R
Abed
A
A
Khrouf
M
M
D000349:Africa; D000352:Africa, Northern; D001695:Biology; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003906:Developing Countries; D003920:Diabetes Mellitus; D004194:Disease; D005193:Family Planning Services; D006331:Heart Diseases; D006973:Hypertension; D007774:Lactation; D016912:Levonorgestrel; D008599:Menstruation Disturbances; D008877:Middle East; D010827:Physiology; D011247:Pregnancy; D011446:Prospective Studies; D012106:Research; D012307:Risk Factors; D014416:Tunisia; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D016912:Levonorgestrel
Africa; Arab Countries; Biology; Clinical Research; Contraception; Contraception Failure; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Implants; Contraceptive Methods; Contraceptive Usage; Developing Countries; Diabetes Mellitus; Diseases; Family Planning; French Speaking Africa; Heart Diseases; Hypertension; Lactation; Levonorgestrel--side effects; Maternal Physiology; Mediterranean Countries; Menstruation Disorders; Northern Africa; Physiology; Prospective Studies; Research Methodology; Research Report; Risk Factors; Studies; Tunisia; Vascular Diseases